CIRCHE — CirChem AB Income Statement
0.000.00%
- SEK85.62m
- SEK79.17m
- SEK20.66m
- 27
- 23
- 26
- 13
Annual income statement for CirChem AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | PRESS |
Standards: | SAS | SAS | SAS | SAS | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.073 | 0.086 | 0.591 | 5.74 | 20.7 |
Cost of Revenue | |||||
Gross Profit | -6.79 | -12.2 | -12.2 | -5.24 | 12.1 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.01 | 16.9 | 20.5 | 21.4 | 20.6 |
Operating Profit | -8.93 | -16.8 | -20 | -15.6 | 0.104 |
Total Net Non Operating Interest Income / Expense | |||||
Net Income Before Taxes | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
Net Income After Taxes | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
Net Income Before Extraordinary Items | |||||
Net Income | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -9.49 | -18.2 | -22.7 | -17.1 | -1.07 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.634 | -1.21 | -1.19 | -0.594 | -0.035 |
Dividends per Share |